TY - JOUR
T1 - Expanding the phenotype of DNAJC30-associated Leigh syndrome
AU - Zawadzka, Marta
AU - Krygier, Magdalena
AU - Pawłowicz, Małgorzata
AU - Wilke, Matheus Vernet Machado Bressan
AU - Rutkowska, Karolina
AU - Gueguen, Naig
AU - Desquiret-Dumas, Valerie
AU - Klee, Eric W.
AU - Schimmenti, Lisa A.
AU - Sławek, Jarosław
AU - Procaccio, Vincent
AU - Płoski, Rafał
AU - Mazurkiewicz-Bełdzińska, Maria
N1 - Funding Information:
The authors thank the patients and their families for participation in the study. M.P. would like to thank the team of radiologists Anna Szalcunas-Olsztyn and Marta Bladowska for their help in the sequential radiological and spectroscopic assessment of the P3.
Publisher Copyright:
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
PY - 2022/11
Y1 - 2022/11
N2 - Leigh syndrome (LS) is a progressive neurodegenerative disease, characterized by extensive clinical, biochemical, and genetic heterogeneity. Recently, biallelic variants in DNAJC30 gene, encoding a protein crucial for the repair of mitochondrial complex I subunits, have been associated with Leber hereditary optic neuropathy and LS. It was suggested that clinical heterogeneity of DNAJC30-associated mitochondrial disease may be attributed to digenic inheritance. We describe three Polish patients, a 9-year-old boy, and female and male siblings, aged 17 and 11 years, with clinical and biochemical manifestations of LS. Exome sequencing (ES) identified a homozygous pathogenic variant in DNAJC30 c.152A>G, p.(Tyr51Cys) in the 9-year-old boy. In the siblings, ES identified two DNAJC30 variants: c.152A>G, p.(Tyr51Cys) and c.130_131del, p.(Ser44ValfsTer8) in a compound heterozygous state. In addition, both siblings carried a novel heterozygous c.484G>T, p.(Val162Leu) variant in NDUFS8 gene. This report provides further evidence for the association of DNAJC30 variants with LS. DNAJC30-associated LS is characterized by variable age at onset, movement disorder phenotype and normal or moderately elevated blood lactate level. Identification of a candidate heterozygous variant in NDUFS8 supports the hypothesis of digenic inheritance. Importantly, DNAJC30 pathogenic variants should be suspected in patients with LS irrespective of optic nerve involvement.
AB - Leigh syndrome (LS) is a progressive neurodegenerative disease, characterized by extensive clinical, biochemical, and genetic heterogeneity. Recently, biallelic variants in DNAJC30 gene, encoding a protein crucial for the repair of mitochondrial complex I subunits, have been associated with Leber hereditary optic neuropathy and LS. It was suggested that clinical heterogeneity of DNAJC30-associated mitochondrial disease may be attributed to digenic inheritance. We describe three Polish patients, a 9-year-old boy, and female and male siblings, aged 17 and 11 years, with clinical and biochemical manifestations of LS. Exome sequencing (ES) identified a homozygous pathogenic variant in DNAJC30 c.152A>G, p.(Tyr51Cys) in the 9-year-old boy. In the siblings, ES identified two DNAJC30 variants: c.152A>G, p.(Tyr51Cys) and c.130_131del, p.(Ser44ValfsTer8) in a compound heterozygous state. In addition, both siblings carried a novel heterozygous c.484G>T, p.(Val162Leu) variant in NDUFS8 gene. This report provides further evidence for the association of DNAJC30 variants with LS. DNAJC30-associated LS is characterized by variable age at onset, movement disorder phenotype and normal or moderately elevated blood lactate level. Identification of a candidate heterozygous variant in NDUFS8 supports the hypothesis of digenic inheritance. Importantly, DNAJC30 pathogenic variants should be suspected in patients with LS irrespective of optic nerve involvement.
KW - DNAJC30
KW - Leigh syndrome
KW - basal ganglia
KW - dystonia
KW - dystonic gait
KW - mitochondrial disease
KW - neurodegenerative disease
KW - optic neuropathy
KW - spasticity
UR - http://www.scopus.com/inward/record.url?scp=85135101529&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85135101529&partnerID=8YFLogxK
U2 - 10.1111/cge.14196
DO - 10.1111/cge.14196
M3 - Article
C2 - 35861300
AN - SCOPUS:85135101529
SN - 0009-9163
VL - 102
SP - 438
EP - 443
JO - Clinical Genetics
JF - Clinical Genetics
IS - 5
ER -